GLI1 and plasma cell myeloma: ADAR1-mediated Alu-dependent RNA editing of glioma-associated oncogene (GLI1), a transcriptional activator of the Hedgehog pathway, promoted immunomodulatory drug resistance in multiple myeloma [256].